Jarred Callura started in August as a Lecturer at the University of Maryland in the Bioengineering Department. Previously, he spent the last year in the Biotechnologies Office of the Defense Advanced Research Projects Agency supporting gene editing and synthetic biology projects. Before then, he spent seven years in industry, five at Intrexon managing animal genome engineering projects and two at United Therapeutics supporting their xenotransplantation effort. Dr. Callura received his PhD in Biomedical Engineering from Boston University in 2012 and his B.S.E. in Biomedical Engineering from Duke University in 2007.
EDUCATION:
Ph.D. in Biomedical Engineering, Boston University
B.S.E. in Biomedical Engineering, Duke University
MISSION AREA:
Professional Highlights
Supported the DARPA Biological Technologies Office’s response to the COVID-19 pandemic. Managed all Intrexon Animal Sciences Division projects, up to seven projects simultaneously, with
cumulative budget over $10 million. Edited the genome of Nile tilapia with CRISPR-Cas9 to increase fillet yield over 50%. Managed multiple xenotransplantation projects across the globe, with results highlighted by the development of a MHC Class I-knockout pig (≥5 genes knocked out using the CRISPR-Cas9 system).
cumulative budget over $10 million. Edited the genome of Nile tilapia with CRISPR-Cas9 to increase fillet yield over 50%. Managed multiple xenotransplantation projects across the globe, with results highlighted by the development of a MHC Class I-knockout pig (≥5 genes knocked out using the CRISPR-Cas9 system).
Papers
Callura, Jarred M., Charles R. Cantor, and James J. Collins. "Genetic switchboard for synthetic biology applications." Proceedings of the National Academy of Sciences 109.15 (2012): 5850-5855.